{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-019359","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2025-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.241483+00:00","generated_at":"2026-05-17T02:20:56.841149+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Vivos Therapeutics expands at-the-market equity offering under existing agreement","bullets":["Filed prospectus supplement to increase aggregate offering price of common stock under ATM agreement with H.C. Wainwright & Co. (dated Feb 14, 2025).","No specific increase amount or prior cap disclosed in the 8-K filing.","Legal opinion on share issuance attached as Exhibit 5.1; no other material changes reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-019359","json":"https://secwatch.observer/filing/0001493152-25-019359.json","markdown":"https://secwatch.observer/filing/0001493152-25-019359.md","text":"https://secwatch.observer/filing/0001493152-25-019359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315225019359/0001493152-25-019359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315225019359/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:20:56.841149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}